Novavax, Inc [NVAX] stock prices are up 11.87% to $8.67 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NVAX shares have gain 16.53% over the last week, with a monthly amount glided 29.60%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On August 20, 2025, downgrade downgraded it’s rating to Underperform but maintained its price target of $7 on the stock. Citigroup started tracking the stock assigning a Sell rating and suggested a price target of $6 on June 17, 2025. BTIG Research initiated its recommendation with a Buy and recommended $19 as its price target on February 28, 2025. JP Morgan downgraded its rating to Underweight for this stock on July 30, 2024, but kept the price target unchanged to $8. In a note dated May 10, 2024, JP Morgan upgraded a Neutral rating on this stock.
The stock price of Novavax, Inc [NVAX] has been fluctuating between $5.01 and $10.64 over the past year. Currently, Wall Street analysts expect the stock to reach $14.5 within the next 12 months. Novavax, Inc [NASDAQ: NVAX] shares were valued at $8.67 at the most recent close of the market. An investor can expect a potential return of 67.24% based on the average NVAX price forecast.
Analyzing the NVAX fundamentals
The Novavax, Inc [NASDAQ:NVAX] reported sales of 1.06B for trailing twelve months, representing a drop of -16.64%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.33%, and Net Profit Margin reading is 0.32%. To continue investigating profitability, this company’s Return on Assets is posted at 0.29, Equity is -1.67 and Total Capital is 0.42. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Novavax, Inc [NASDAQ:NVAX]’s Current Ratio is 2.27. Also, the Quick Ratio is 2.24, while the Cash Ratio stands at 0.62. Considering the valuation of this stock, the price to sales ratio is 1.32 and price to earnings (TTM) ratio is 4.90.
Transactions by insiders
Recent insider trading involved YOUNG JAMES F, Former Director, that happened on May 19 ’25 when 10000.0 shares were purchased. Former Director, YOUNG JAMES F completed a deal on Apr 14 ’25 to buy 4000.0 shares.
